Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Country/Region as subject
Language
Publication year range
1.
Emerg Infect Dis ; 29(1): 145-148, 2023 01.
Article in English | MEDLINE | ID: mdl-36573733

ABSTRACT

In July 2019, Bourbon virus RNA was detected in an Amblyomma americanum tick removed from a resident of Long Island, New York, USA. Tick infection and white-tailed deer (Odocoileus virginianus) serosurvey results demonstrate active transmission in New York, especially Suffolk County, emphasizing a need for surveillance anywhere A. americanum ticks are reported.


Subject(s)
Deer , Ticks , Animals , New York/epidemiology , Arachnid Vectors
2.
Emerg Infect Dis ; 27(12): 3128-3132, 2021 12.
Article in English | MEDLINE | ID: mdl-34648421

ABSTRACT

During 2018, Heartland virus RNA was detected in an Amblyomma americanum tick removed from a resident of Suffolk County, New York, USA. The person showed seroconversion. Tick surveillance and white-tailed deer (Odocoileus virginianus) serosurveys showed widespread distribution in Suffolk County, emphasizing a need for disease surveillance anywhere A. americanum ticks are established or emerging.


Subject(s)
Deer , Phlebovirus , Ticks , Animals , Humans , New York/epidemiology
3.
Ticks Tick Borne Dis ; 10(2): 407-411, 2019 02.
Article in English | MEDLINE | ID: mdl-30573383

ABSTRACT

In North America, Lyme disease (LD) is caused predominantly by the spirochete Borrelia burgdorferisensu stricto, and is transmitted by blacklegged ticks. Long Island, New York, is highly endemic for the disease. The C6 peptide (C6P) is currently used as a screening test for LD in our institution. Our objective was to examine how screening with C6P concorded with diagnosis of LD at the Veterans Affairs Medical Center, Northport, Long Island. A retrospective chart-review of 2558 C6P tests was performed during the period of 1/1/2010 to 12/31/2016. Patients were categorized by Lyme Disease (LD) or no LD groups. LD group was defined as having an erythema migrans (EM) rash, or ≥ 2 IgM bands or ≥ 5 IgG bands on immunoblot. Out of the 409 patients with positive or equivocal C6P, 181 patients with LD were based on presence of EM, or Western blot IgM and IgG test results; 228 did not have LD. The positive predictive value of C6P was 44.5%. EM was the most common presentation. In the LD group, history of tick bite (P: 0.0001), headache (P: 0.0036), joint swelling (P: 0.0086) and myalgias (P: 0.0005) were more likely to be present. Zip code mapping of our cases mirrored those previously reported in the Suffolk County Department of Health. In our review we encountered a significant number of false positive C6 assays. False positive C6P tests were ordered by primary care physicians (PCP) (37%) followed by neurologists (33%). A history of tick exposure and clinical findings of early Lyme disease such as headaches or joint aches were more likely to denote a true positive C6 peptide test. Rigorous education of physicians about Lyme disease and pitfalls of our available diagnostic tests are needed for their proper utilization.


Subject(s)
Bacterial Proteins/blood , Lyme Disease/epidemiology , Peptides/blood , Veterans , Aged , Antibodies, Bacterial/blood , Arthralgia/etiology , Borrelia , Endemic Diseases , Erythema Chronicum Migrans/microbiology , False Positive Reactions , Female , Headache/etiology , Humans , Immunoblotting , Immunoglobulin G/blood , Immunoglobulin M/blood , Lyme Disease/diagnosis , Male , Middle Aged , New York/epidemiology , Retrospective Studies , Tick Bites/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL